Subtype
Malignant Pharyngeal Neoplasm
CI-CAN-00003219Explore in graph →
411 active trials1 approved drugs2 evidence items
- NCIt
- C7545
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003219Explore in graph →
Clinical trials
1,255 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (112)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00697905 | Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma | completed | Phase 2 | 18 | Ministry of Health, MalaysiaOTHER_GOV | 1 | Nov 21, 2014 | clinicaltrials |
| NCT01254734 | Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer | terminated | N/A | 7 | City of Hope Medical CenterOTHER | 1 | Nov 10, 2014 | clinicaltrials |
| NCT00507767 |
| Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer |
| completed |
| Phase 2 |
| 15 |
| National Cancer Institute (NCI)NIH |
| 1 |
| Oct 1, 2014 |
| clinicaltrials |
| NCT01718223 | Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer | withdrawn | N/A | 0 | Roswell Park Cancer InstituteOTHER | 0 | Sep 3, 2014 | clinicaltrials |
| NCT01682031 | Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy | terminated | Phase 2 | 18 | Roswell Park Cancer InstituteOTHER | 2 | Aug 22, 2014 | clinicaltrials |
| NCT01403259 | SOX as Salvage Treatment in Nasopharyngeal Carcinoma | terminated | Phase 2 | 16 | Fudan UniversityOTHER | 1 | Aug 20, 2014 | clinicaltrials |
| NCT01175499 | Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract(TNFE-NBI) | withdrawn | N/A | 0 | University of California, San FranciscoOTHER | 0 | Aug 19, 2014 | clinicaltrials |
| NCT00387335 | Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer | completed | Phase 2 | 22 | National Cancer Institute (NCI)NIH | 1 | Jul 25, 2014 | clinicaltrials |
| NCT02187315 | Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical Study | unknown | Phase 2 | 160 | Feng JingOTHER | 1 | Jul 11, 2014 | clinicaltrials |
| NCT00141765 | Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers | completed | Phase 2 | 25 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 20, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00049283 | Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jun 6, 2014 | clinicaltrials |
| NCT02149641 | Parotid-sparing IMRT for Nasopharyngeal Cancer | completed | — | 42 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 29, 2014 | clinicaltrials |
| NCT00705627 | A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 400 | Sun Yat-sen UniversityOTHER | 1 | May 28, 2014 | clinicaltrials |
| NCT00103259 | Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 71 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT00492089 | Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | May 9, 2014 | clinicaltrials |
| NCT00513435 | Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 9 | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2014 | clinicaltrials |
| NCT01937793 | Swallowing Exercises for Nasopharyngeal Cancer After Radiation Therapy | completed | N/A | 16 | National Taiwan University HospitalOTHER | 1 | Apr 17, 2014 | clinicaltrials |
| NCT02016417 | Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma | unknown | Phase 2 | 120 | Cancer Hospital of Guangxi Medical UniversityOTHER | 0 | Apr 16, 2014 | clinicaltrials |
| NCT01439724 | Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients | completed | Phase 3 | 94 | Instituto Nacional de Cancer, BrazilOTHER_GOV | 1 | Apr 11, 2014 | clinicaltrials |
| NCT01358097 | Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy | completed | — | 33 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Apr 10, 2014 | clinicaltrials |
| NCT02096380 | The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | — | 120 | First People's Hospital of FoshanOTHER | 0 | Mar 26, 2014 | clinicaltrials |
| NCT01712919 | Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC) | completed | Phase 1 / Phase 2 | 61 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Mar 24, 2014 | clinicaltrials |
| NCT02089204 | Hypoxia Imaging -Guided Radiotherapy of Nasopharyngeal Carcinoma | unknown | — | 300 | Xuzhou Medical UniversityOTHER | 0 | Mar 17, 2014 | clinicaltrials |
| NCT01417390 | Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 2 | 80 | First People's Hospital of FoshanOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT01612286 | Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 30 | Zhejiang Cancer HospitalOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT01245959 | Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 476 | Sun Yat-sen UniversityOTHER | 1 | Feb 13, 2014 | clinicaltrials |
| NCT02044562 | Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients | unknown | N/A | 20 | Capital Medical UniversityOTHER | 1 | Jan 24, 2014 | clinicaltrials |
| NCT00943891 | A Study of Lymphangiogenesis in Colorectal and Nasopharyngeal Cancer | unknown | — | 500 | National University Hospital, SingaporeOTHER | 1 | Jan 22, 2014 | clinicaltrials |
| NCT00098631 | Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer | completed | Phase 2 | 88 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2014 | clinicaltrials |
| NCT01884987 | Treatment of Cerebral Radiation Necrosis With GM1, a Prospective Study | unknown | — | 30 | Fudan UniversityOTHER | 1 | Jan 7, 2014 | clinicaltrials |
| NCT01865201 | Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis | completed | Phase 2 | 154 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Dec 12, 2013 | clinicaltrials |
| NCT01728480 | Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy | withdrawn | Phase 1 | 0 | Roswell Park Cancer InstituteOTHER | 0 | Dec 11, 2013 | clinicaltrials |
| NCT01347424 | Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Dec 9, 2013 | clinicaltrials |
| NCT00055770 | Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer | completed | Phase 1 / Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Nov 25, 2013 | clinicaltrials |
| NCT00095641 | S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer | withdrawn | Phase 2 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Nov 8, 2013 | clinicaltrials |
| NCT01596868 | GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China | completed | Phase 2 | 60 | Air Force Military Medical University, ChinaOTHER | 1 | Oct 30, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00049166 | Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT01271439 | Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma(REPLACE) | completed | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 1 | Aug 13, 2013 | clinicaltrials |
| NCT01854203 | Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC(NPC) | unknown | Phase 2 / Phase 3 | 300 | Sun Yat-sen UniversityOTHER | 1 | Jul 30, 2013 | clinicaltrials |
| NCT00677118 | Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 506 | Sun Yat-sen UniversityOTHER | 1 | Jul 12, 2013 | clinicaltrials |
| NCT00006106 | ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00780312 | Physiotherapy Treatment for Patients Suffering From Head and Neck Cancer(HOHF) | completed | Phase 2 | 97 | Rigshospitalet, DenmarkOTHER | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00906360 | Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck | terminated | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00101270 | Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT01155609 | L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer | completed | N/A | 10 | University of WashingtonOTHER | 1 | May 17, 2013 | clinicaltrials |
| NCT01674374 | Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy | withdrawn | Phase 2 | 0 | Roswell Park Cancer InstituteOTHER | 0 | May 15, 2013 | clinicaltrials |
| NCT00410826 | Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | 204 | University of WashingtonOTHER | 1 | May 10, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Nov 21, 2014source: clinicaltrials